Nuvectra Corporation (NVTR) Expected to Announce Earnings of -$1.16 Per Share
Equities research analysts predict that Nuvectra Corporation (NASDAQ:NVTR) will announce ($1.16) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Nuvectra Corporation’s earnings. Nuvectra Corporation posted earnings per share of ($0.92) in the same quarter last year, which would suggest a negative year-over-year growth rate of 26.1%. The business is scheduled to issue its next quarterly earnings results on Wednesday, November 8th.
According to Zacks, analysts expect that Nuvectra Corporation will report full year earnings of ($4.77) per share for the current year. For the next year, analysts forecast that the business will post earnings of ($4.12) per share. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research analysts that follow Nuvectra Corporation.
Nuvectra Corporation (NASDAQ:NVTR) last announced its quarterly earnings data on Tuesday, August 8th. The company reported ($1.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.14) by $0.07. The business had revenue of $7.20 million for the quarter, compared to analysts’ expectations of $5.96 million. Nuvectra Corporation had a negative return on equity of 56.68% and a negative net margin of 232.31%. The company’s revenue for the quarter was up 188.0% compared to the same quarter last year. During the same period last year, the firm earned ($0.85) earnings per share.
A number of analysts recently weighed in on NVTR shares. TheStreet raised shares of Nuvectra Corporation from a “d” rating to a “c-” rating in a research report on Monday, June 19th. ValuEngine raised shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a research report on Friday, June 16th. Zacks Investment Research raised shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, May 30th. Finally, Piper Jaffray Companies reissued a “neutral” rating and issued a $14.00 price objective on shares of Nuvectra Corporation in a research report on Thursday, July 6th. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $10.50.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/09/24/nuvectra-corporation-nvtr-expected-to-announce-earnings-of-1-16-per-share.html.
Nuvectra Corporation (NVTR) traded up 0.58% during mid-day trading on Friday, reaching $12.08. The company’s stock had a trading volume of 28,914 shares. The stock’s 50 day moving average price is $11.56 and its 200 day moving average price is $11.56. Nuvectra Corporation has a 1-year low of $4.63 and a 1-year high of $12.19. The stock’s market capitalization is $129.26 million.
In other Nuvectra Corporation news, CEO Scott F. Drees acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The shares were purchased at an average price of $11.72 per share, for a total transaction of $117,200.00. Following the completion of the purchase, the chief executive officer now directly owns 125,180 shares in the company, valued at $1,467,109.60. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.60% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Gilder Gagnon Howe & Co. LLC raised its stake in Nuvectra Corporation by 12.5% during the second quarter. Gilder Gagnon Howe & Co. LLC now owns 953,431 shares of the company’s stock worth $12,662,000 after acquiring an additional 105,580 shares during the period. Dimensional Fund Advisors LP raised its stake in Nuvectra Corporation by 3.1% during the second quarter. Dimensional Fund Advisors LP now owns 701,849 shares of the company’s stock worth $9,321,000 after acquiring an additional 21,140 shares during the period. Vanguard Group Inc. raised its stake in Nuvectra Corporation by 6.2% during the second quarter. Vanguard Group Inc. now owns 310,794 shares of the company’s stock worth $4,128,000 after acquiring an additional 18,081 shares during the period. Hodges Capital Management Inc. raised its stake in Nuvectra Corporation by 18.6% during the second quarter. Hodges Capital Management Inc. now owns 227,807 shares of the company’s stock worth $3,025,000 after acquiring an additional 35,706 shares during the period. Finally, Essex Investment Management Co. LLC raised its stake in Nuvectra Corporation by 42.1% during the second quarter. Essex Investment Management Co. LLC now owns 202,623 shares of the company’s stock worth $2,691,000 after acquiring an additional 60,034 shares during the period. Hedge funds and other institutional investors own 57.21% of the company’s stock.
About Nuvectra Corporation
Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with MarketBeat.com's FREE daily email newsletter.